However, there was no association between neogenin expression and other clinicopathological parameters, such as tumor size, lymph node status, vascular invasion status, breast cancer subtype, TNM stage, and biomarker (ER, PR, HER-2, and Ki67). The gene discussed is ESR1; the disease is breast cancer.